Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001896463 | SCV002166379 | uncertain significance | Jeune thoracic dystrophy; Nephronophthisis | 2022-03-19 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 453 of the TTC21B protein (p.Met453Val). This variant is present in population databases (rs754773733, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with TTC21B-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV002463061 | SCV002756734 | uncertain significance | not provided | 2022-05-18 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002482729 | SCV002789041 | uncertain significance | Asphyxiating thoracic dystrophy 4; Nephronophthisis 12 | 2024-06-11 | criteria provided, single submitter | clinical testing |